when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

(decitabine + tetrahydrouridine) · news · pharmadog

← back to (decitabine + tetrahydrouridine)

News mentioning (decitabine + tetrahydrouridine)

12 stories

May 13, 26Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practiceonclive

May 13, 26FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive

May 13, 26FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphomaonclive

May 13, 26Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLonclive

May 13, 26Combination and Sequencing Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Treatment Sequencing in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Patient Selection for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Alpha-Emitting Therapies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Combination Radiopharmaceutical Approaches in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Radiopharmaceutical Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26BRUIN CLL-321 Trial Impact and Treatment Selectiononclive

May 13, 26Biomarker-Driven Treatment Decisions and Managing Progression After Frontline Immunotherapyonclive